Search
for
Sort by
Research 391–420 of 1000+
- NGHIÊN CỨU TÁC DỤNG HẠ ĐƯỜNG HUYẾT CỦA CAO CHIẾT HÀNH TÍM (ALLIUM ASCALONICUM L., ALLIACEAE) TRÊN MÔ HÌNH CHUỘT GÂY TĂNG ĐƯỜNG HUYẾT BẰNG ALLOXAN
- Cover Image
- Hair growth promoting effects of human dermal papilla cells in pig
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- Permanent alopecia following chemotherapy and bone marrow transplantation
- RSPO1, a potent inducer of pancreatic β cell neogenesis
- Hyaluronate Fragments Reverse Skin Atrophy by a CD44-Dependent Mechanism
- Macrophages Regulate Schwann Cell Maturation after Nerve Injury
- A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity
- Assessing diagnostic skill in dermatology: A comparison between general practitioners and dermatologists
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
- Phenotypic variability associated with<i>WNT10A</i>nonsense mutations
- The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis
- Alopecia Areata is Associated with Increased Expression of Heart Disease Biomarker Cardiac Troponin I
- Alopecia areata in underrepresented groups: preliminary analysis of the all of us research program
- Cutaneous Manifestations of Mucopolysaccharidoses
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Erosive Lichen Sclerosus—A Clinicopathologic Subtype
- Extensive Hair Shaft Growth after Mouse Whisker Follicle Isolation, Cryopreservation and Transplantation in Nude Mice
- Characteristics of Patients with Hair Loss after Isotretinoin Treatment
- Porocarcinoma: an epidemiological, clinical, and dermoscopic 20‐year study
- The Effectiveness of Oral Mini-Pulse Methylprednisolonein - the Treatment of Alopecia Areata in Vietnam
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Perceived Stigma Among Adults With Alopecia Areata in the United States
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Integrated Safety Analysis of Ritlecitinib in Adolescent Patients with Alopecia Areata from the Randomized, Placebo-Controlled ALLEGRO Phase 2b/3 and Ongoing Open-Label Phase 3 ALLEGRO-LT Studies
- 42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
- Platelet-Rich Fibrin Matrix